Evo Antegrade
Payments companies reported to CMS as associated with Evo Antegrade. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Evo Antegrade, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Evo Antegrade
These are the largest totals companies reported as associated with Evo Antegrade. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Justin Haller | Salt Lake City, UT | Orthopaedic Trauma | $10,216.60 |
| James Learned | Orange, CA | Orthopaedic Trauma | $9,665.74 |
| Gilbert Ortega | Scottsdale, AZ | Orthopaedic Trauma | $6,375.00 |
| Laura Prokuski | Scottsdale, AZ | Orthopaedic Surgery | $4,870.26 |
| Casey Cates | Dallas, TX | Orthopaedic Surgery | $3,437.30 |
| Dirk Kiner | Chattanooga, TN | Orthopaedic Surgery | $2,616.80 |
| Charles Moon | Los Angeles, CA | Orthopaedic Surgery | $2,336.95 |
| Aaron Perdue | Ann Arbor, MI | Orthopaedic Surgery | $2,292.71 |
| David Polonet | Neptune, NJ | Orthopaedic Surgery | $2,150.37 |
| Thomas Kovack | Dublin, OH | Orthopaedic Surgery | $2,094.46 |
Prescribed Evo Antegrade?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.